lumacaftor/ivacaftor, tezacaftor/ivacaftor, and elexacaftor/tezacaftor/ivacaftor which are used to treat people with cystic fibrosis. Ivacaftor was developed...
34 KB (3,170 words) - 00:46, 12 November 2024
Elexacaftor/tezacaftor/ivacaftor, sold under the brand names Trikafta and Kaftrio, is a fixed-dose combination medication used to treat cystic fibrosis...
38 KB (3,107 words) - 08:02, 24 June 2024
Lumacaftor/ivacaftor, sold under the brand name Orkambi among others, is a combination of lumacaftor and ivacaftor used to treat people with cystic fibrosis...
15 KB (1,370 words) - 07:39, 4 July 2024
Reimbursement of ORKAMBI® (lumacaftor/ivacaftor) and SYMKEVI® (tezacaftor/ivacaftor) in Combination With KALYDECO® (ivacaftor)". www.businesswire.com. 21 October...
37 KB (3,630 words) - 01:25, 19 October 2024
with ivacaftor under the brand name Symdeko. It was approved by the U.S. FDA in 2018. The combination of elexacaftor, tezacaftor, and ivacaftor is being...
11 KB (724 words) - 19:14, 30 November 2023
available in a single pill with ivacaftor and tezacaftor; the fixed-dose combination, elexacaftor/tezacaftor/ivacaftor (brand name Trikafta), is used to...
7 KB (286 words) - 14:34, 17 May 2024
cell surface. It is available in a single pill with ivacaftor; the combination, lumacaftor/ivacaftor (brand name Orkambi), is used to treat people with...
4 KB (171 words) - 13:20, 28 March 2024
R07AX01 Nitric oxide R07AX02 Ivacaftor R07AX30 Ivacaftor and lumacaftor R07AX31 Ivacaftor and tezacaftor R07AX32 Ivacaftor, tezacaftor and elexacaftor...
1,000 bytes (237 words) - 06:04, 4 January 2021
cystic fibrosis. Ivacaftor is a medication taken by mouth for the treatment of CF due to a number of specific mutations responsive to ivacaftor-induced CFTR...
161 KB (18,189 words) - 19:11, 5 November 2024
(COPD) and cystic fibrosis. The drug is being developed by Novartis. Like ivacaftor (which is marketed as Kalydeco), icenticaftor functions by acting as a...
6 KB (241 words) - 16:38, 7 June 2024